Healthcare -
Biotechnology - NASDAQ - US
$ 7.72
-4.1 %
$ 5.38 M
Market Cap
0.0
P/E
RNAZ - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss RNAZ - TransCode Therapeutics, Inc.
0
LAST VALUE
41.42%
2 YEAR CAGR
14.87%
5 YEAR CAGR
0.00%
10 YEAR CAGR